Stay updated with breaking news from Akeso inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company"), a commercial-stage biopharmaceutical company focused on developing and commercializing...
Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso"), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and...
China Drug Regulator Mulls Tightening Conditional Approvals informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ -- Akeso Inc. (9926. HK) ("Akeso") today announced that the Journal for Immunotherapy of Cancer (JITC), a BMJ oncology journal, published the...
(Reuters) - Summit Therapeutics Inc said on Tuesday it has signed a licensing deal worth up to $5 billion with China-based Akeso Inc for an experiment...
Summit Therapeutics Inc said on Tuesday it has signed a licensing deal worth up to $5 billion with China-based Akeso Inc for an experimental cancer therapy. Summit said it would make an... | December 6, 2022
(Reuters) - Summit Therapeutics Inc said on Tuesday it has signed a licensing deal worth up to $5 billion with China-based Akeso Inc for an experiment...
(Reuters) - Summit Therapeutics Inc said on Tuesday it has signed a licensing deal worth up to $5 billion with China-based Akeso Inc for an experiment...